These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 20508173)

  • 1. Alloimmunization to red blood cell antigens by transfusion.
    Mintz PD
    Blood; 2010 May; 115(21):4315; author reply 4315-6. PubMed ID: 20508173
    [No Abstract]   [Full Text] [Related]  

  • 2. Red blood cell alloimmunization among sickle cell Kuwaiti Arab patients who received red blood cell transfusion.
    Ameen R; Al Shemmari S; Al-Bashir A
    Transfusion; 2009 Aug; 49(8):1649-54. PubMed ID: 19453992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Red blood cell alloimmunization and minor red blood cell antigen phenotypes in transfused Ghanaian patients with sickle cell disease.
    Boateng LA; Campbell AD; Davenport RD; Osei-Akoto A; Hugan S; Asamoah A; Schonewille H
    Transfusion; 2019 Jun; 59(6):2016-2022. PubMed ID: 30758856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alloimmunization in transfused patients with constitutional anemias in Norway.
    Furuseth MT; Alme C; Garvik LJ; Hellebostad M; Bechensteen AG; Akkök ÇA
    Transfus Apher Sci; 2021 Oct; 60(5):103257. PubMed ID: 34420880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Red blood cell alloimmunization: lessons from sickle cell disease.
    Treml A; King KE
    Transfusion; 2013 Apr; 53(4):692-5. PubMed ID: 23565994
    [No Abstract]   [Full Text] [Related]  

  • 6. Risk of alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease.
    Cox JV; Steane E; Cunningham G; Frenkel EP
    Arch Intern Med; 1988 Nov; 148(11):2485-9. PubMed ID: 3142382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Transfusion and alloimmunization in sickle cell anemia patients].
    Norol F; Nadjahi J; Bachir D; Desaint C; Guillou Bataille M; Beaujean F; Bierling P; Bonin P; Galacteros F; Duedari N
    Transfus Clin Biol; 1994; 1(1):27-34. PubMed ID: 8186850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Alloimmunization in poly-transfused patients with hemoglobin S disease].
    Gómez Oliva P; Basanta Otero P; González Villalonga C; Batista Veranes M; Orbeal Aldama L; García Echevarría M
    Sangre (Barc); 1985; 30(4-A):406-10. PubMed ID: 4071354
    [No Abstract]   [Full Text] [Related]  

  • 9. Impact of red blood cell alloimmunization on sickle cell disease mortality: a case series.
    Nickel RS; Hendrickson JE; Fasano RM; Meyer EK; Winkler AM; Yee MM; Lane PA; Jones YA; Pashankar FD; New T; Josephson CD; Stowell SR
    Transfusion; 2016 Jan; 56(1):107-14. PubMed ID: 26509333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Red Blood Cell Antigen Matching on Alloimmunization and Transfusion Complications in Patients with Sickle Cell Disease: A Systematic Review.
    Fasano RM; Meyer EK; Branscomb J; White MS; Gibson RW; Eckman JR
    Transfus Med Rev; 2019 Jan; 33(1):12-23. PubMed ID: 30122266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Red blood cell alloimmunization is influenced by recipient inflammatory state at time of transfusion in patients with sickle cell disease.
    Fasano RM; Booth GS; Miles M; Du L; Koyama T; Meier ER; Luban NL
    Br J Haematol; 2015 Jan; 168(2):291-300. PubMed ID: 25256676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Red cell antibodies in patients with homozygous sickle cell disease: a comparison of patients in Jamaica and the United Kingdom.
    Olujohungbe A; Hambleton I; Stephens L; Serjeant B; Serjeant G
    Br J Haematol; 2001 Jun; 113(3):661-5. PubMed ID: 11380455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experience with donors matched for minor blood group antigens in patients with sickle cell anemia who are receiving chronic transfusion therapy.
    Ambruso DR; Githens JH; Alcorn R; Dixon DJ; Brown LJ; Vaughn WM; Hays T
    Transfusion; 1987; 27(1):94-8. PubMed ID: 3810834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic evaluation of a hypothetical screening assay for alloimmunization risk among transfused patients with sickle cell disease.
    Kacker S; Ness PM; Savage WJ; Frick KD; Shirey RS; King KE; Tobian AA
    Transfusion; 2014 Aug; 54(8):2034-44. PubMed ID: 24571485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Red blood cell alloimmunization in sickle cell disease-prevalence and trends: a single-center cross-sectional study from United Kingdom.
    Mijovic A; Perera IG; Thein SL
    Transfusion; 2013 Dec; 53(12):3279-80. PubMed ID: 24320815
    [No Abstract]   [Full Text] [Related]  

  • 16. Red cell alloimmunization in sickle-cell anaemia patients.
    Bashawri LA
    East Mediterr Health J; 2007; 13(5):1181-9. PubMed ID: 18290412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for alloimmunization in patients with sickle cell anemia.
    Pinto PC; Braga JA; Santos AM
    Rev Assoc Med Bras (1992); 2011; 57(6):668-73. PubMed ID: 22249547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Red blood cell alloimmunization from an African perspective.
    Natukunda B; Brand A; Schonewille H
    Curr Opin Hematol; 2010 Nov; 17(6):565-70. PubMed ID: 20827185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relevance of blood groups in transfusion of sickle cell disease patients.
    Noizat-Pirenne F
    C R Biol; 2013 Mar; 336(3):152-8. PubMed ID: 23643398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stochastic modeling of human RBC alloimmunization: evidence for a distinct population of immunologic responders.
    Higgins JM; Sloan SR
    Blood; 2008 Sep; 112(6):2546-53. PubMed ID: 18535200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.